What is ACAD stock price today?

Visit our real-time dashboard for the current ACAD stock price and live market data.

Is ACAD stock going up or down today?

ACAD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACAD stock now?

The decision to buy ACAD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACAD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACAD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACAD stock overvalued or undervalued?

ACAD currently trades at a P/E ratio of 15.29 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ACAD is fairly priced.

What is ACAD's P/E ratio?

ACAD has a price-to-earnings (P/E) ratio of 15.29, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ACAD's market cap?

ACAD (ACADIA Pharmaceuticals Inc) has a market capitalization of $3.51 billion, making it a small-cap stock.

What is ACAD's price to book ratio?

Price-to-book ratio for ACAD is available on our dashboard along with other valuation metrics.

Does ACAD pay dividends?

ACAD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACAD's dividend yield?

ACAD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACAD stock a good long-term investment?

ACAD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACAD's revenue growth rate?

Revenue growth data for ACAD is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACAD are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACAD?

Key risks for ACAD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACAD compare to its competitors?

Compare ACAD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACAD's performance and positioning.

What is ACAD's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ACAD with bull, base, and bear case scenarios.

What do analysts say about ACAD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACAD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACAD's next earnings report?

ACAD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACAD - ACADIA Pharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc (ACAD) common stock

Price Chart

Loading chart...

ACAD Key Statistics

Market Cap

$3.51B

P/E Ratio

15.29

How ACAD Compares to Peers

ACAD ranks 2nd most undervalued by P/E ratio among peers

ACAD is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACAD(This stock)	$3.51B	15.3	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 7:28 PM EDT

Ready to invest in ACAD?

Commission-free trading available. Affiliate links.

ACAD Lician Score

10% confidence

6.0/10

Good

ACAD has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACADacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACAD Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACAD

Dashboard

Enter a ticker to analyze